Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 32, Issue 4, 2018, Pages 1627-1634

  Maeda, Takuma ^a   Ishihara, Takuma ^b   Miyata, Shigeki ^a   Yamashita, Kizuku ^a   Sasaki, Hiroaki ^a   Kobayashi, Junjiro ^a   Ohnishi, Yoshihiko ^a   Nishimura, Kunihiro ^a   Shintani, Ayumi ^b   Iso, Hiroyasu ^c  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b Osaka Prefecture University   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

blood transfusion; cardiovascular diseases; tranexamic acid

Indexed keywords

FENTANYL; PROPOFOL; REMIFENTANIL; ROCURONIUM; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR SURGERY; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE POLICY; HEART ARREST; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SENSITIVITY ANALYSIS; SURGICAL MORTALITY; THROMBOSIS; TIME SERIES ANALYSIS; TREATMENT DURATION; MIDDLE AGED; MORTALITY; TRENDS;

AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CARDIOVASCULAR SURGICAL PROCEDURES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 85034634503     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2017.10.018     Document Type: Article

References (20)

1. Robich, M.P., Koch, C.G., Johnston, D.R., et al. Trends in blood utilization in United States cardiac surgical patients. Transfusion 55 (2015), 805–814.
2. Utley, J.R., Wilde, E.F., Leyland, S.A., et al. Intraoperative blood transfusion is a major risk factor for coronary artery bypass grafting in women. Ann Thorac Surg 60 (1995), 570–574 574–5.
3. Sprung, J., Abdelmalak, B., Gottlieb, A., et al. Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery. Anesthesiology 93 (2000), 129–140.
4. Karkouti, K., Wijeysundera, D.N., Yau, T.M., et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 44 (2004), 1453–1462.
5. Williamson, L.M., Devine, D.V., Challenges in the management of the blood supply. Lancet 381 (2013), 1866–1875.
6. Ip, P.P., Lam, K.W., Cheung, C.L., et al. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: A clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. Am J Surg Pathol 31 (2007), 1215–1224.
7. Koster, A., Borgermann, J., Zittermann, A., et al. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: Incidence and clinical outcome. Br J Anaesth 110 (2013), 34–40.
8. Ng, W., Jerath, A., Wasowicz, M., Tranexamic acid: A clinical review. Anaesthesiol Intensive Ther 47 (2015), 339–350.
9. Sharma, V., Katznelson, R., Jerath, A., et al. The association between tranexamic acid and convulsive seizures after cardiac surgery: A multivariate analysis in 11 529 patients. Anaesthesia 69 (2014), 124–130.
10. Kalavrouziotis, D., Voisine, P., Mohammadi, S., et al. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 93 (2012), 148–154.
11. Okita, Y., Miyata, H., Motomura, N., et al. A study of brain protection during total arch replacement comparing antegrade cerebral perfusion versus hypothermic circulatory arrest, with or without retrograde cerebral perfusion: Analysis based on the Japan Adult Cardiovascular Surgery Database. J Thorac Cardiovasc Surg 149 (2015), S65–S73.
12. D'Agostino, R.B. Jr., Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998), 2265–2281.
13. Austin, P.C., The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments. Stat Med 3 (2014), 1242–1258.
14. Stiell, I.G., Wells, G.A., Field, B., et al. Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med 351 (2004), 647–656.
15. Wagner, A.K., Soumerai, S.B., Zhang, F., et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27 (2002), 299–309.
16. Tagami, T., Hirata, K., Takeshige, T., et al. Implementation of the fifth link of the chain of survival concept for out-of-hospital cardiac arrest. Circulation 126 (2012), 589–597.
17. Sander, M., Spies, C.D., Martiny, V., et al. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: A retrospective analysis. Crit Care, 14, 2010, R148.
18. Myles, P.S., Smith, J.A., Painter, T., Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med, 376, 2017, 1893.
19. Makhija, N., Sarupria, A., Kumar Choudhary, S., et al. Comparison of epsilon aminocaproic acid and tranexamic acid in thoracic aortic surgery: Clinical efficacy and safety. J Cardiothorac Vasc Anesth 27 (2013), 1201–1207.
20. Murkin, J.M., Falter, F., Granton, J., et al. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 110 (2010), 350–353.